Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LIX1L | CTRPv2 | pan-cancer | AAC | -0.23 | 4e-07 |
mRNA | AMPD2 | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-07 |
mRNA | TERF2IP | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-06 |
mRNA | EDC4 | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-07 |
mRNA | ARL3 | CTRPv2 | pan-cancer | AAC | -0.2 | 8e-07 |
mRNA | SYDE1 | CTRPv2 | pan-cancer | AAC | -0.19 | 6e-05 |
mRNA | BRD8 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-07 |
mRNA | GNA11 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0001 |
mRNA | PRPS1 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
mRNA | EID2B | CTRPv2 | pan-cancer | AAC | -0.18 | 7e-06 |